About Us

Established in 2011, BioSpeedia develops and manufactures a portfolio of innovative in vitro diagnostics (IVD) rapid test kits and ELISA kits for medical professionals and clinical diagnostic markets worldwide.

Latest News

Covid-19 : une nouvelle campagne de dépistage débute le 13 janvier à Saint-Etienne…

Saint-Étienne : la campagne de dépistage massive du Covid démarre la semaine prochaine…

Covid : un nouveau test antigénique 100% français sur le marché…

Our Products

image_2020_10_09T14_15_31_157Z
COVID-19 Our Products
11VIRUS-QNATEST-mobileMasterAt3x
Human Infectious Diseases Rapid Tests Our Products
Header méningite
MeningoSpeed Our Products

CE marked COVID-19 rapid test kits

Our Rapid Antigen Test Kit is an immunochromatographic assay designed for the qualitative detection of specific SARS-CoV-2 antigen in human nasopharyngeal swab specimen. It is intended to be used for the detection of SARS-CoV-2 virus infection. This protocol can be carried out in 15 minutes and is simple in its implementation.

Our Rapid Antibody Test Kit is an immunochromatographic assay designed for the qualitative detection and differentiation of specific IgM and IgG antibodies to coronavirus 2019-nCoV or SARS-CoV-2 in human fingertip blood samples. It is intended to be used for the detection of SARS-CoV-2 virus infection. This protocol can be carried out in 15 minutes and is simple in its implementation.

Our PCR Test Kit offers a combination of Viral Nucleic Acid Extraction Kit and 2019 nCoV Multiplex RT qPCR Kit, with the ability to complete the entire process from nucleic acid purification to RT-qPCR assay within 3.5 hours.

Click image to view the Certification

Please click the logo to view or download the certificate

BioSpeedia is a biotechnology company founded by two scientific researchers from Institut Pasteur.

We develop and manufacture a portfolio of innovative in vitro diagnostics rapid test kits for medical professionals and clinical diagnostic markets worldwide.